What are the recommended starting and maintenance doses of Synthroid (levothyroxine) for adults, including elderly patients and those with cardiac disease, and how should the dose be adjusted?

Synthroid Dosing Recommendations

For young healthy adults (<50 years) with overt hypothyroidism, start with full replacement doses of approximately 1.6-1.7 mcg/kg/day (typically 100-125 mcg/day for a 70 kg adult), while patients over 50-60 years without cardiac disease should start at 50 mcg daily, and those with known cardiac disease must start at 12.5-25 mcg/day with gradual titration. 1, 2

Starting Doses by Patient Population

Young Healthy Adults (<50 years, No Cardiac Disease)

• Start with full replacement: 1.6-1.7 mcg/kg/day 2
• Typical dose: 100-125 mcg/day for a 70 kg adult 2
• This approach allows faster normalization of TSH without increased risk 1

Older Adults (>50-60 years, No Cardiac Disease)

• Start at 50 mcg daily 1, 2
• Increase gradually at 6-8 week intervals 2
• Elderly patients require 20-25% less per kilogram than younger patients due to decreased lean body mass 1
• Recent evidence suggests older adults need only 1.09 mcg/kg actual body weight or 1.35 mcg/kg ideal body weight for maintenance—one-third lower than younger populations 3

Patients with Known Cardiac Disease (Any Age)

• Start at 12.5-25 mcg/day 2
• Increase by 12.5-25 mcg increments at 4-6 week intervals 2
• Monitor closely for anginal symptoms 1
• Critical pitfall: Starting too high or titrating too quickly can precipitate myocardial infarction or worsen angina 4, 5

Subclinical Hypothyroidism

• Start at 25-75 mcg daily depending on TSH elevation 1
• Lower doses than overt hypothyroidism are sufficient 1
• One validated approach: 25 mcg for TSH 4.0-8.0 mIU/L, 50 mcg for TSH 8-12 mIU/L, 75 mcg for TSH >12 mIU/L 1

Severe Hypothyroidism

• Start at 12.5-25 mcg/day 2
• Increase by 25 mcg every 2-4 weeks with close monitoring 2
• Lower starting dose prevents cardiovascular complications

Maintenance Dosing

• Average full replacement: 1.6-1.7 mcg/kg/day for younger adults 2
• Elderly patients: Often require <1 mcg/kg/day 2
• Doses >200 mcg/day are seldom required 2
• Inadequate response to ≥300 mcg/day suggests non-compliance, malabsorption, or drug interactions 2

Dose Adjustments

Timing of adjustments:

• Check TSH 4-8 weeks after initiation or dose change 1
• Peak therapeutic effect may take 4-6 weeks due to levothyroxine's long half-life 2
• Once stable, monitor at 6-month then 12-month intervals 1

Increment size:

• Adjust in 12.5-25 mcg increments 1, 2
• Smaller adjustments may be needed to achieve target TSH 1

Administration Guidelines

• Take 30-60 minutes before breakfast with water OR at bedtime 4 hours after last meal 1
• Must be taken at least 4 hours apart from drugs interfering with absorption 2
• Store at 20-25°C (68-77°F), protected from light and moisture 1

Special Populations

Pregnancy

• TSH should be measured promptly after conception 1
• Target TSH <2.5 mIU/L in first trimester, <3.0 mIU/L in second trimester, <3.5 mIU/L in third trimester 1
• Monitor TSH every 4 weeks during first half of pregnancy 1
• Most pregnant women require dose increases 1

Obesity

• Use ideal body weight for dose calculations, not actual body weight 1
• Obese patients on actual body weight dosing average 0.9 mcg/kg vs 1.42 mcg/kg ideal body weight 3

Cardiac Disease Considerations

The evidence shows that properly dosed levothyroxine actually reduces cardiovascular events in hypothyroid patients with CVD 6. However, the key is cautious initiation—most patients with preexisting angina experience gradual improvement, but initial therapy can precipitate ischemia if started too aggressively 4. In unstable angina requiring coronary bypass, surgery can be safely performed while moderately hypothyroid, but elective procedures should wait until euthyroid 1.

Critical Pitfalls to Avoid

1. Starting too high in elderly or cardiac patients: Can precipitate MI, arrhythmias, or angina 2, 4
2. Checking TSH too early: Wait full 4-8 weeks before assessing dose adequacy 1
3. Overtreatment: Suppressed TSH increases risk of atrial fibrillation (especially elderly) and bone loss (postmenopausal women) 7, 1, 2
4. Using actual body weight in obese patients: Leads to overdosing; use ideal body weight 1, 3
5. Not screening for adrenal insufficiency: Must treat with glucocorticoids before starting levothyroxine to prevent adrenal crisis 1, 2